| Line Item | 2022-10-30 | Y/Y |
|---|---|---|
| Revenue | $33.20B | +21.0% |
| Cost of Revenue | $11.11B | +4.7% |
| Gross Profit | $22.09B | +31.2% |
| R&D Expense | $4.92B | +1.3% |
| SG&A Expense | $1.38B | +2.6% |
| Operating Income | $14.22B | +67.0% |
| Interest Expense | $1.74B | -7.9% |
| Pre-tax Income | $12.43B | +83.8% |
| Income Tax | $939.0M |
| Line Item | 2022-10-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.42B | +2.1% |
| Accounts Receivable | $2.96B | +42.8% |
| Inventory | $1.93B | +48.4% |
| Current Assets | $18.50B | +11.6% |
| Total Assets | $73.25B | -3.1% |
| Current Liabilities | $7.05B | +12.3% |
| Long-term Debt | $39.08B | -1.5% |
| Line Item | 2022-10-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.74B | +21.6% |
| Capital Expenditures | $424.0M | -4.3% |
| Investing Cash Flow | -$667.0M | -172.2% |
| Financing Cash Flow | -$15.82B | -76.2% |
| Free Cash Flow | $16.31B | +22.5% |
| +3137.9% |
| Net Income | $11.49B | +70.7% |
| EPS (Basic) | $27.44 | +74.8% |
| EPS (Diluted) | $26.53 | +76.9% |
| Total Liabilities |
| $50.54B |
| -0.1% |
| Stockholders' Equity | $22.71B | -9.0% |